Compound Nanoemulsion Combined with Differentiation/Cytotoxicity Drugs for Modulating Breast Cancer Stemness

In vivo antitumor efficacy showed that the compound nanoemulsion could reduce the proportion of breast cancer stem cells to 1.18% by inhibiting the expression of Pin1.